The purpose of this paper was to investigate the effects of hemolysis on the fetal fraction of cell-free DNA (cfDNA). The effects on determining the probability of fetal trisomies was also investigated.
Hemolysis and Fetal Fraction in Cell-Free DNA Blood Collection Tubes for Noninvasive Prenatal Testing.
Stokowski R, White K, Hacker C, Doshi J, Schmid M
Purpose
Conclusion
Different levels of hemolysis were observed between tubes for 49% of patients despite tubes being collected from the same blood draw. The fetal fraction cfDNA was comparable between replicate tubes, regardless of differences in hemolysis and was unaffected by hemolysis in the 12,908 specimens sent to the laboratory. Further, the fetal fraction of cfDNA was very strongly correlated between matched tubes, regardless of the difference in hemoglobin concentration. There were no differences in fetal trisomy probability results due to hemolysis for chromosomes 21, 18, or 13 between the matched tubes for any of the 115 patients with matched specimens.
Studies (1)
Purpose
The purpose of this study was to investigate the effects of hemolysis on the fetal fraction of cfDNA. The effects on determining the probability of fetal trisomies was also investigated. Blood was drawn from 115 pregnant women (≥10-weeks gestation, mean 16 weeks) into three replicate Roche Cell-Free DNA Collection Tubes. Blood specimens were shipped overnight to Ariosa Diagnostics with appropriate temperature monitors and stored for up to 7 days at room temperature before plasma isolation (details not provided). Temperature monitoring revealed 9% of specimens were exposed to temperatures <10°C and 41% of specimens were exposed to temperatures >30°C. Hemolysis was evaluated visually. DNA content was evaluated using the Microarray based Harmony Prenatal Test. The effects of hemolysis were further investigated by comparing the fetal fraction of DNA from 12,908 specimens submitted to the Ariosa diagnostics lab, 203 of which were significantly hemolyzed (>500 mg/dL hemoglobin). For these specimens, details of collection and processing were not included but 99% were collected in Roche Cell-Free DNA Collection Tubes with the remaining specimens collected in Streck Cell-Free DNA BCT tubes.
Summary of Findings
Different levels of hemolysis were observed between tubes for 49% of patients (56 of 115), despite tubes being collected from the same blood draw. The authors state these differences may have been due to differences in tube age, exposure of blood to temperature extremes, blood draw order, vein collapse, or differences in blood mixing after collection. Three tubes did not yield sufficient plasma for further analysis. Analysis of the remaining 339 plasma specimens revealed no differences in hemoglobin levels between tubes for 210 specimens, a difference of 50-200 mg/dL for 64 specimens, a difference of 250-450 mg/dL for 42 specimens, and a difference of 500-1000 mg/dL for 23 specimens. The fetal fraction cfDNA was not significantly different between tubes in any of the groups and was unaffected by hemolysis in the 12,908 specimens sent to the laboratory. Further, the fetal fraction was very strongly correlated between matched tubes, regardless of the difference in hemoglobin concentration (r2=0.94 for no difference, r2=0.90 for difference of 50-200 mg/dL, r2=0.92 for difference of 250-450 mg/dL, and r2=0.93 for difference of 500-1000 mg/dL). Further, there were no differences in fetal trisomy probability results due to hemolysis for chromosomes 21, 18, or 13 between the matched tubes for any of the 115 patients.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
None (Fresh)Diagnoses
PregnantPlatforms
DNADNA microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Hemolysis AbsentPresent